Patent 10492685 was granted and assigned to Abbott on December, 2019 by the United States Patent and Trademark Office.
Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user.